Journal article
P10 Treatment-refractory psoriasiform dermatitis resulting from a rare genetic alteration in MSMO1 with marked improvement with combined cholesterol and statin use
- Abstract:
- An infant of 19 months presented to dermatology with a widespread psoriasiform rash favouring inguinal and neck flexures. There was a known family history of psoriasis but no other concerns reported. This progressed to become erythrodermic despite multiple topical treatments as well as systemic treatments including ciclosporin and zinc supplements. Skin biopsy suggested psoriasis or nutritional deficiency. Oral acitretin reduced skin severity significantly. However, there was continued impact from areas of inflammatory skin with only partial response to topical treatments. Other syndromic features were apparent from presentation and developed over follow-up with global developmental delay, microcephaly, congenital cataracts corrected age 3, and skeletal abnormalities (inward curving little finger). A genetic defect in an enzyme in the cholesterol pathway was subsequently confirmed with alteration (compound heterozygous) in MSM01 gene which code for methylsterol-monoxygenase-1enzyme. Deficiency in this key player in cholesterol synthesis causes downstream deficiencies in hormones and other compounds required for healthy development and functioning. It also causes an upstream accumulation of toxic methylsterols. This results in this rare metabolic condition with neurodevelopmental, dermatological, ocular and skeletal manifestations. Topical (2% simvastatin/2% cholesterol cream) and oral statin was commenced to reduce the toxic accumulation of methylsterols, along with cholesterol replacement to replace the downstream deficiency. Improvement in her skin, with almost complete clearance after only after a few months of treatment has been life changing. Awareness of potential genetic metabolic causes of childhood skin conditions is key to ensure appropriate support and early effective treatments.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 57.9KB, Terms of use)
-
- Publisher copy:
- 10.1093/bjd/ljaf465.018
Authors
- Publisher:
- Oxford University Press
- Journal:
- British Journal of Dermatology More from this journal
- Volume:
- 193
- Issue:
- Supplement_3
- Article number:
- ljaf465.018
- Publication date:
- 2025-12-19
- DOI:
- EISSN:
-
1365-2133
- ISSN:
-
0007-0963
- Language:
-
English
- Pubs id:
-
2352700
- Local pid:
-
pubs:2352700
- Source identifiers:
-
3578174
- Deposit date:
-
2025-12-19
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
If you are the owner of this record, you can report an update to it here: Report update to this record